![discount label](https://static.cymitquimica.com/public/img/discount.png)
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc & Avi), Biotinylated
Ref. TM-TMPK-01002
1mg | 5.185,00 € | ||
100µg | 802,00 € | ||
500µg | 3.098,00 € |
Información del producto
- HECL, DCAL-2, CD303, CLECSF7, DCAL2, CLECSF11, CLL1, CLL-1, CD371, MICL, PRO34150, CLEC12A, DLEC
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with N-hFc-Avi tag. The predicted molecular weight is 51.7 kDa and the accession number is Q5QGZ9-2.
Propiedades químicas
Consulta técnica sobre: TM-TMPK-01002 CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc & Avi), Biotinylated
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.